Entry |
|
Name |
Moexipril hydrochloride (USP); Univasc (TN) |
Product |
|
Generic |
|
Formula |
C27H34N2O7. HCl
|
Exact mass |
534.2133
|
Mol weight |
535.029
|
Structure |
|
Simcomp |
|
Class |
Cardiovascular agent
DG01925 Renin-angiotensin system inhibitor
DG01501 Angiotensin-converting enzyme inhibitor
DG03231 Antihypertensive
DG01501 Angiotensin-converting enzyme inhibitor
|
Remark |
Product (DG00344): | D00623<US> |
|
Efficacy |
Antihypertensive, Angiotensin-converting enzyme inhibitor |
Disease |
|
Target |
|
Pathway |
|
Interaction |
|
Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
C CARDIOVASCULAR SYSTEM
C09 AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
C09A ACE INHIBITORS, PLAIN
C09AA ACE inhibitors, plain
C09AA13 Moexipril
D00623 Moexipril hydrochloride (USP) <US>
USP drug classification [BR:br08302]
Cardiovascular Agents
Angiotensin-converting Enzyme (ACE) Inhibitors
Moexipril
D00623 Moexipril hydrochloride (USP)
Drug groups [BR:br08330]
Cardiovascular agent
DG01925 Renin-angiotensin system inhibitor
DG01501 Angiotensin-converting enzyme inhibitor
DG00344 Moexipril
D00623 Moexipril hydrochloride
DG03231 Antihypertensive
DG01501 Angiotensin-converting enzyme inhibitor
DG00344 Moexipril
D00623 Moexipril hydrochloride
Drug classes [BR:br08332]
Cardiovascular agent
DG01501 Angiotensin-converting enzyme inhibitor
D00623 Moexipril hydrochloride
DG03231 Antihypertensive
D00623 Moexipril hydrochloride
Target-based classification of drugs [BR:br08310]
Enzymes
Hydrolases (EC3)
Peptidyl-dipeptidases
ACE (CD143)
D00623 Moexipril hydrochloride (USP) <US>
Drug groups [BR:br08330]
Cardiovascular agent
DG01925 Renin-angiotensin system inhibitor
DG01501 Angiotensin-converting enzyme inhibitor
DG00344 Moexipril
DG03231 Antihypertensive
DG01501 Angiotensin-converting enzyme inhibitor
DG00344 Moexipril
|
Other DBs |
|
KCF data |
ATOM 37
1 C8y C 27.9060 -17.6765
2 C8y C 27.9060 -16.2768
3 C1x C 26.7072 -18.3734
4 C8x C 29.1167 -18.3734
5 C1x C 26.6953 -15.5799
6 C8x C 29.1109 -15.5741
7 N1y N 25.4907 -17.6883
8 C8y C 30.3274 -17.6705
9 C1y C 25.4847 -16.2828
10 C8y C 30.3274 -16.2768
11 C5a C 24.2800 -18.3852
12 O2a O 31.5380 -18.3674
13 C6a C 25.4729 -14.8890
14 O2a O 31.5321 -15.5741
15 C1c C 23.0633 -17.6883
16 O5a O 24.2858 -19.7908
17 C1a C 32.7487 -17.6705
18 O6a O 26.6777 -14.1745
19 O6a O 24.2504 -14.1979
20 C1a C 32.7487 -16.2709
21 N1b N 21.8468 -18.3852
22 C1a C 23.0693 -16.2828
23 C1c C 20.6420 -17.6942
24 C1b C 19.4255 -18.3970
25 C7a C 20.6361 -16.2886
26 C1b C 18.2088 -17.7120
27 O7a O 21.8468 -15.5859
28 O6a O 19.4137 -15.5917
29 C8y C 16.9981 -18.3970
30 C1b C 21.8408 -14.1861
31 C8x C 16.9981 -19.8144
32 C8x C 15.7934 -17.7120
33 C1a C 20.6302 -13.4892
34 C8x C 15.7934 -20.5229
35 C8x C 14.5710 -18.3970
36 C8x C 14.5710 -19.8144
37 X Cl 36.0853 -16.8969
BOND 38
1 1 2 2
2 1 3 1
3 1 4 1
4 2 5 1
5 2 6 1
6 3 7 1
7 4 8 2
8 5 9 1
9 6 10 2
10 7 11 1
11 8 12 1
12 9 13 1 #Down
13 10 14 1
14 11 15 1
15 11 16 2
16 12 17 1
17 13 18 1
18 13 19 2
19 14 20 1
20 15 21 1
21 15 22 1 #Up
22 21 23 1
23 23 24 1
24 23 25 1 #Up
25 24 26 1
26 25 27 1
27 25 28 2
28 26 29 1
29 27 30 1
30 29 31 1
31 29 32 2
32 30 33 1
33 31 34 2
34 32 35 1
35 34 36 1
36 7 9 1
37 8 10 1
38 35 36 2
|